Summary
Intratumoral platinum concentrations were measured in three tumor sites (head and neck, uterine cervix, and breast) 48 h after cisplatin administration according to the same protocol.
The platinum levels were in the same order of magniude in all tumors, but the concentration in breast tumors was found to be higher than that in tumors of the head and neck and of the uterine cervix.
References
Bonnem EM, Litterst CL, Smith FP (1982) Platinum concentrations in human glioblastoma multiforme following the use of cisplatin. Cancer Treat Rep 66: 1661
Gibaldi M, Perrier D (1975) Pharmacokinetics. Dekker, New York
Harrison R, Mc Auliffe CA, Zaki A, Baer J, Sharma H, Smith A, Jackson H, Fox BW (1983) A comparative study of the distribution in the male rat of platinum labeled cis-dichlorodiammine platinum (II), cis-trans dichlorodihydroxy-bis-(isopropylamine) platinum (IV) and cis-dichloro-bis-cyolopropylamine platinum (II). Cancer Chemother Pharmacol 10: 90
Hecquet B, Adenis L, Demaille A (1983) In vitro interactions of TN06 with human plasma. Cancer Chemother Pharmacol 11: 177
Jacobs SC, Mc Cellan SL, Maher C, Lawson R (1984) Precystectomy intraarterial cis-diamminedichlorophlatinum II with local bladder hyperthermia for bladder cancer. J Urol 131: 473
Lange RC, Spencer RP, Harder HC (1973) The antitumour agent cisPt (NH3)2 C12; distribution studies and dose calculations for 193mPt and 195mPt. J Nucl Med 14: 191
Leroy AF, Wehling ML, Sponseller HL, Litterst CL, Gram TE, Guarino AM, Becher DA (1977) Analysis of platinum in biological materials by Flameless Atomic Absorption Spectrophotometry. Biochem Med 18: 184
Litterst CL, Gram TE, Dedrick RJ, Le Roy AF, Guarino AM (1976) Distribution and disposition of platinum following administration of cis-diamminodichloroplatinum (II) (NSC 119875) to dogs. Cancer Res 36: 2340
Litterst CL, Torres IJ, Guarino AM (1977) Plasma levels and organ distribution of platinum in the rat, dog and dogfish shark following single intravenous administration of cisdichlorodiammine platinum (II). J Clin Haematol Oncol 7: 169
Litters CL, Le Roy AF, Guarino AM (1979) Disposition and distribution of platinum following parenteral adminstration of cis-dichlorodiammine platinum (II) to animals. Cancer Treat Rep 63: 1485
Meites L (1983) The general non-linear regression program CFT 4A. Clarkson College of Technology, Postdam, New York
Smith PHS, Taylor DM (1974) Distribution and retention of the antitumour agents 195mPt cis-dichlorodiammine platinum (II) in man. J Nucl Med 15: 349
Steward DJ, Benjamin RS, Luna M, Feun L, Caprioli R, Seifert W, Ti Li Loo (1982a) Human tissue distribution of platinum after cis-diamminedichloroplatinum. Cancer Chemother Pharmacol 10: 51
Steward DJ, Leavens M, Maor M, Feun L, Luna M, Bonura J, Caprioli R, Ti Li Loo, Benjamin RS (1982b) Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 42: 2474
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hecquet, B., Vennin, P., Fournier, C. et al. Platinum concentration in human tumors of head and neck, uterine cervix, and breast following treatment with cisplatin. Cancer Chemother. Pharmacol. 15, 310–312 (1985). https://doi.org/10.1007/BF00263908
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00263908